STOCK TITAN

RB Global director granted dividend equivalent rights

A director of RB Global received additional dividend equivalent rights tied to existing deferred share units and RSUs, increasing his contingent economic exposure to common shares.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

RB GLOBAL INC. (symbol: RBA) is the issuer of record for a Form 4 filing submitted to the SEC. Bales Brian A reported acquisition or exercise transactions in this Form 4 filing.

RB GLOBAL INC. (RBA) reported that director Brian A. Bales received four awards of dividend equivalent rights on September 17, 2026, tied to his existing deferred share units and restricted share units.

The awards cover 9 dividend equivalent rights related to deferred share units, 11 rights linked to 2024 RSUs, 8 rights linked to 2025 RSUs, and 8 rights linked to 2026 RSUs, each at $0.00 per right and held directly. According to the company’s disclosure, each dividend equivalent right represents a contingent right to receive the economic equivalent of one RB Global common share and becomes exercisable concurrently or proportionately with the underlying deferred share units or RSUs. No Rule 10b5-1 trading plan is reported for these transactions.

Positive

  • None.

Negative

  • None.
Insider Bales Brian A
Role Director
Type Security Shares Price Value
Grant/Award Dividend Equivalent Rights (DSUs) F1 9 $0.00 $0.00
Grant/Award Dividend Equivalent Rights (2024 RSUs) F2 11 $0.00 $0.00
Grant/Award Dividend Equivalent Rights (2025 RSUs) F3 8 $0.00 $0.00
Grant/Award Dividend Equivalent Rights (2026 RSUs) F4 8 $0.00 $0.00
Holdings After Transaction: Dividend Equivalent Rights (DSUs) — 82 contracts (Direct); Dividend Equivalent Rights (2024 RSUs) — 84 contracts (Direct); Dividend Equivalent Rights (2025 RSUs) — 35 contracts (Direct); Dividend Equivalent Rights (2026 RSUs) — 14 contracts (Direct)
Footnotes (4)
  1. F1. The dividend equivalent rights accrued in respect of the reporting person's deferred share units, and become exercisable and payable concurrently with the deferred share units. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share.
  2. F2. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. The dividend equivalent rights accrued in respect of the 2024 grant of restricted share units (RSU), and become exercisable proportionately with the restricted share units to which they relate.
  3. F3. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. The dividend equivalent rights accrued in respect of the 2025 grant of restricted share units (RSU), and become exercisable proportionately with the restricted share units to which they relate.
  4. F4. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. The dividend equivalent rights accrued in respect of the 2026 grant of restricted share units (RSU), and become exercisable proportionately with the restricted share units to which they relate.
Dividend equivalent rights (deferred share units) granted 9 rights Grant to director on September 17, 2026, at $0.00 per right
Dividend equivalent rights (2024 RSUs) granted 11 rights Grant to director on September 17, 2026, at $0.00 per right
Dividend equivalent rights (2025 RSUs) granted 8 rights Grant to director on September 17, 2026, at $0.00 per right
Dividend equivalent rights (2026 RSUs) granted 8 rights Grant to director on September 17, 2026, at $0.00 per right
Dividend equivalent rights (deferred share units) after transaction 82 rights Director’s holdings following September 17, 2026 grant
Dividend equivalent rights (2024 RSUs) after transaction 84 rights Director’s holdings following September 17, 2026 grant
Dividend equivalent rights (2025 RSUs) after transaction 35 rights Director’s holdings following September 17, 2026 grant
Dividend equivalent rights (2026 RSUs) after transaction 14 rights Director’s holdings following September 17, 2026 grant
Dividend Equivalent Rights financial
"The dividend equivalent rights accrued in respect of the reporting person's deferred share units"
Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.
deferred share units financial
"The dividend equivalent rights accrued in respect of the reporting person's deferred share units"
Deferred share units are promises that give an executive or director the right to receive company shares or their cash value at a future date, often when they retire or leave the company. Think of them as a paycheck held in a savings account that converts into stock later; they matter to investors because they tie pay to long-term performance, create potential future dilution of shares, and represent a delayed cash or share obligation the company must eventually fulfill.
restricted share units (RSU) financial
"The dividend equivalent rights accrued in respect of the 2024 grant of restricted share units (RSU)"
economic equivalent financial
"Each dividend equivalent right represents a contingent right to receive the economic equivalent"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did RB Global (RBA) disclose for Brian A. Bales?

RB Global disclosed that director Brian A. Bales received four grants of dividend equivalent rights on September 17, 2026, tied to his deferred share units and 2024, 2025, and 2026 restricted share unit (RSU) awards.

How many dividend equivalent rights were granted to the RB Global (RBA) director?

The director received 9 dividend equivalent rights related to deferred share units, 11 related to 2024 RSUs, 8 related to 2025 RSUs, and 8 related to 2026 RSUs, each at a reported price of $0.00 per right.

What do the dividend equivalent rights at RB Global (RBA) represent?

Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RB Global common share. They accrue on deferred share units or RSUs and become exercisable concurrently or proportionately with the underlying units.

When do the RB Global (RBA) dividend equivalent rights become exercisable?

Dividend equivalent rights on deferred share units become exercisable and payable concurrently with those deferred share units. Rights linked to the 2024, 2025, and 2026 RSUs become exercisable proportionately as the related RSUs vest or become exercisable.

Were the RB Global (RBA) insider transactions under a Rule 10b5-1 plan?

No. The disclosure indicates that no Rule 10b5-1 trading plan is reported for these September 17, 2026 dividend equivalent right awards to the RB Global director.

How many dividend equivalent rights does the RB Global (RBA) director hold after these grants?

After the September 17, 2026 grants, the director holds 82 dividend equivalent rights tied to deferred share units, 84 tied to 2024 RSUs, 35 tied to 2025 RSUs, and 14 tied to 2026 RSUs, each representing a contingent economic equivalent of one common share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bales Brian A

(Last)(First)(Middle)
C/O RB GLOBAL, INC.
2 WESTBROOK CORPORATE CENTER

(Street)
WESTCHESTER ILLINOIS 60154

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
RB GLOBAL INC. [ RBA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Dividend Equivalent Rights (DSUs)(1)09/17/2026A9 (1) (1)Common Shares9$082D
Dividend Equivalent Rights (2024 RSUs)(2)09/17/2026A11 (2) (2)Common Shares11$084D
Dividend Equivalent Rights (2025 RSUs)(3)09/17/2026A8 (3) (3)Common Shares8$035D
Dividend Equivalent Rights (2026 RSUs)(4)09/17/2026A8 (4) (4)Common Shares8$014D
Explanation of Responses:
1. The dividend equivalent rights accrued in respect of the reporting person's deferred share units, and become exercisable and payable concurrently with the deferred share units. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share.
2. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. The dividend equivalent rights accrued in respect of the 2024 grant of restricted share units (RSU), and become exercisable proportionately with the restricted share units to which they relate.
3. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. The dividend equivalent rights accrued in respect of the 2025 grant of restricted share units (RSU), and become exercisable proportionately with the restricted share units to which they relate.
4. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. The dividend equivalent rights accrued in respect of the 2026 grant of restricted share units (RSU), and become exercisable proportionately with the restricted share units to which they relate.
/s/ Maria Teresa Punsalan, attorney-in-fact for Brian Bales09/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading